News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
292,337 Results
Type
Article (15645)
Company Profile (302)
Press Release (276384)
Multimedia
Podcasts (79)
Webinars (13)
Section
Business (83207)
Career Advice (386)
Deals (13746)
Drug Delivery (46)
Drug Development (51120)
Employer Resources (66)
FDA (6025)
Job Trends (5444)
News (149744)
Policy (10520)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1005)
Accelerated approval (19)
Adcomms (16)
Allergies (84)
Alliances (22239)
ALS (124)
Alzheimer's disease (1059)
Antibody-drug conjugate (ADC) (242)
Approvals (6218)
Artificial intelligence (268)
Autoimmune disease (113)
Automation (10)
Bankruptcy (108)
Best Places to Work (4795)
BIOSECURE Act (6)
Biosimilars (103)
Biotechnology (231)
Bladder cancer (103)
Brain cancer (46)
Breast cancer (354)
Cancer (3180)
Cardiovascular disease (247)
Career advice (338)
Career pathing (13)
CAR-T (221)
CDC (7)
Cell therapy (572)
Cervical cancer (14)
Clinical research (44009)
Collaboration (1170)
Company closure (2)
Compensation (593)
Complete response letters (40)
COVID-19 (1131)
CRISPR (86)
C-suite (566)
Cystic fibrosis (116)
Data (4391)
Denatured (16)
Depression (94)
Diabetes (263)
Diagnostics (1505)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (23)
Drug discovery (192)
Drug pricing (54)
Drug shortages (3)
Duchenne muscular dystrophy (214)
Earnings (32529)
Editorial (29)
Employer branding (8)
Employer resources (59)
Events (53325)
Executive appointments (650)
FDA (7829)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (996)
Gene editing (182)
Generative AI (21)
Gene therapy (491)
GLP-1 (515)
Government (1266)
Grass and pollen (3)
Guidances (182)
Healthcare (7038)
HIV (22)
Huntington's disease (43)
IgA nephropathy (75)
Immunology and inflammation (192)
Immuno-oncology (40)
Indications (69)
Infectious disease (1240)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (42)
Intellectual property (167)
Interviews (60)
IPO (7504)
IRA (13)
Job creations (907)
Job search strategy (282)
JPM (43)
Kidney cancer (9)
Labor market (34)
Layoffs (251)
Leadership (14)
Legal (1503)
Liver cancer (43)
Longevity (11)
Lung cancer (432)
Lymphoma (249)
Machine learning (24)
Management (19)
Manufacturing (393)
MASH (134)
Medical device (2984)
Medtech (2994)
Mergers & acquisitions (6879)
Metabolic disorders (743)
Multiple sclerosis (105)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (71)
Neuroscience (1989)
Neurotech (1)
NextGen: Class of 2026 (2215)
Non-profit (1074)
Now hiring (31)
Obesity (336)
Opinion (145)
Ovarian cancer (131)
Pain (106)
Pancreatic cancer (161)
Parkinson's disease (233)
Partnered (16)
Patents (304)
Patient recruitment (329)
Peanut (44)
People (28567)
Pharmaceutical (46)
Pharmacy benefit managers (8)
Phase 1 (15532)
Phase 2 (20414)
Phase 3 (12980)
Pipeline (3295)
Policy (96)
Postmarket research (889)
Preclinical (6560)
Press Release (30)
Prostate cancer (147)
Psychedelics (51)
Radiopharmaceuticals (238)
Rare diseases (662)
Real estate (1517)
Recruiting (23)
Regulatory (10190)
Reports (26)
Research institute (1034)
Resumes & cover letters (51)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (124)
Series A (184)
Series B (135)
Service/supplier (1)
Sickle cell disease (79)
Special edition (20)
Spinal muscular atrophy (120)
Sponsored (19)
Startups (2035)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (22)
The Weekly (62)
Vaccines (346)
Venture capital (74)
Weight loss (178)
Women's health (25)
Worklife (5)
Date
Last 7 days (354)
Last 30 days (1187)
Last 365 days (18202)
2026 (1700)
2025 (18499)
2024 (21002)
2023 (22936)
2022 (28025)
2021 (28582)
2020 (24258)
2019 (17442)
2018 (12581)
2017 (14197)
2016 (12309)
2015 (14837)
2014 (10816)
2013 (7776)
2012 (7907)
2011 (8004)
2010 (7698)
Location
Africa (194)
Alabama (65)
Alaska (3)
Arizona (75)
Arkansas (5)
Asia (18669)
Australia (3194)
California (7150)
Canada (1881)
China (781)
Colorado (250)
Connecticut (274)
Delaware (236)
Europe (40453)
Florida (924)
Georgia (220)
Hawaii (3)
Idaho (17)
Illinois (405)
India (35)
Indiana (178)
Iowa (9)
Japan (229)
Kansas (80)
Kentucky (10)
Louisiana (7)
Maine (14)
Maryland (765)
Massachusetts (5650)
Michigan (115)
Minnesota (254)
Mississippi (3)
Missouri (34)
Montana (16)
Nebraska (6)
Nevada (34)
New Hampshire (21)
New Jersey (1689)
New Mexico (14)
New York (1802)
North Carolina (848)
North Dakota (6)
Northern California (3509)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1312)
Puerto Rico (11)
Rhode Island (26)
South America (263)
South Carolina (12)
Southern California (2840)
Tennessee (40)
Texas (923)
United States (23784)
Utah (102)
Virginia (138)
Washington D.C. (39)
Washington State (602)
West Virginia (1)
Wisconsin (48)
292,337 Results for "perspective therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Radiopharmaceuticals
Perspective Therapeutics Brings Energy to the Radiopharma World
The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and speedy speech.
June 6, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Tisento Therapeutics Announces Publication of MELAS Interview Study, Incorporating Patients’ Perspectives to Elucidate Symptoms and Impacts of Rare Mitochondrial Disease
November 4, 2025
·
5 min read
Press Releases
L7 Informatics Shares Industry Perspectives on the Digital Infrastructure Required to Scale Cell Therapy Manufacturing
December 9, 2025
·
1 min read
Sponsored
Viral Vector Manufacturing: Case Studies and Considerations from a CDMO Perspective
Optimization Through Culture, Quality Control and Regulatory Standards
November 3, 2025
·
14 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Biotech Bay
Switch Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Switch Therapeutics today announced that Dee Datta, Ph.D., co-founder and CEO of Switch Therapeutics, will present and host investor meetings at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024.
June 25, 2024
·
1 min read
Spur Therapeutics to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Spur Therapeutics, formerly Freeline Therapeutics, today announced that Chief Executive Officer Michael Parini will participate in a fireside chat at H.C. Wainwright’s 5th Annual Neuro Perspectives Virtual Conference being held on June 27th, 2024.
June 20, 2024
·
1 min read
Press Releases
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
September 12, 2025
·
5 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics, Inc. to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
June 12, 2025
·
5 min read
Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Alexandra MacLean, M.D., Chief Executive Officer of Avenue Therapeutics, will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference.
June 20, 2024
·
1 min read
1 of 29,234
Next
